Clinical efficacy of ribavirin combined with different doses of interferon α-2b in patients with chronic hepatitis C genotypes 2 and 3

ObjectiveTo investigate the clinical efficacy of ribavirin (RBV) combined with different doses of interferon α-2b (IFN α-2b) in patients with chronic hepatitis C genotypes 2 and 3. MethodsForty-six patients who were admitted for chronic hepatitis C genotypes 2 and 3 from April 2009 to January 2012...

Full description

Bibliographic Details
Main Author: ZHAO Xiaoling
Format: Article
Language:zho
Published: Editorial Department of Journal of Clinical Hepatology 2013-10-01
Series:Linchuang Gandanbing Zazhi
Subjects:
Online Access:http://www.lcgdbzz.org/qk_content.asp?id=5494&ClassID=82214258